PharmaCorp Rx Inc. Announces Second Quarter 2026 Financial Results
SASKATOON, Saskatchewan, Aug. 20, 2026 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“ PharmaCorp ” or the “ Corporation ”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, today reported its financial results for the three and six months ended June 30, 2026.
“Our second quarter reflected continued organic growth, disciplined integration, and active execution of acquisitions,” said Alan Simpson, Executive Chair of PharmaCorp. “With the closing of nine pharmacy acquisitions in July, together with the completion of the pharmacy acquisition in Western Canada on August 17, we are building momentum in our strategy to acquire, integrate and operate high-quality community pharmacies across Canada.”
A welcome email is on its way. If you don't see it, please check your junk folder.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.
